Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Melatonin for delirium in elderly medical inpatients
ACTRN12614000101684Phase 3Completed
- Sponsor
- Royal Melbourne Hospital
- Start
- May 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of melatonin in delirium (2 arms), sponsored by Royal Melbourne Hospital. Primary endpoint: Symptoms of delirium. Started May 2014; status: completed.
02
Drugs
melatonin
03
Conditions
delirium
Beyond the preview
Go deeper on ACTRN12614000101684.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12614000101684.